Tdo2 - tryptophan 2,3-dioxygenase Gene
Also Known as TO; TDO; chky
Species: Mus musculus
Summary
Predicted to enable several functions, including heme binding activity; identical protein binding activity; and tryptophan 2,3-dioxygenase activity. Predicted to be involved in protein homotetramerization; tryptophan catabolic process to acetyl-CoA; and tryptophan catabolic process to kynurenine. Predicted to act upstream of or within tryptophan catabolic process. Is expressed in cerebellum; liver; male reproductive gland or organ; and small intestine. Human ortholog(s) of this gene implicated in Gilles de la Tourette syndrome and familial hypertryptophanemia. Orthologous to human TDO2 (tryptophan 2,3-dioxygenase). [provided by Alliance of Genome Resources, Apr 2022]
Tdo2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_019911.2 | NP_064295.2 | tryptophan 2,3-dioxygenase |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
tryptophan 2,3-dioxygenase |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-133677 | Mono(2-ethyl-5-hydroxyhexyl) phthalate | 99.03% | Unkown | |
| HY-170322 | TDO2-IN-1 | 99.44% | Unkown | |
| HY-114319 | β-Cembrenediol | 98.16% | Unkown | |
| HY-161996 | IDO1-IN-25 | Inhibitor | / | Unkown |
| HY-184027 | IDO1/TDO-IN-12 | Inhibitor | / | Unkown |
| HY-184028 | IDO1-IN-37 | Inhibitor | / | Unkown |
| HY-184079 | TDO2-IN-2 | / | Unkown | |
| HY-RS14331 | TDO2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W1011921 | TDO2-IN-3 | / | Unkown | |
| HY-RS18976 | Tdo2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25465 | Tdo2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service